{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:49:44Z","timestamp":1792633784658,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neuroscience.2017.08.023","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:16:51Z","timestamp":1503548211000},"page":"141-151","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["An altered blood\u2013brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"362","author":[{"given":"Sonia","family":"Olmedo-D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Est\u00e9vez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greger","family":"Or\u00e4dd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"af Bjerk\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marcellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Virel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2017.08.023_b0005","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1089\/ars.2005.7.1140","article-title":"Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources","volume":"7","author":"Adam-Vizi","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood\u2013brain barrier P-glycoprotein function in the progression of Parkinson\u2019s disease, PSP and MSA","volume":"115","author":"Bartels","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0015","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1471-4159.1991.tb06432.x","article-title":"Intranigral iron injection induces behavioral and biochemical \u201cparkinsonism\u201d in rats","volume":"57","author":"Ben-Shachar","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1471-4159.2001.00608.x","article-title":"Brain iron pathways and their relevance to Parkinson's disease","volume":"79","author":"Berg","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","article-title":"Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy","volume":"119","author":"Bradaric","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0035","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1523\/JNEUROSCI.5480-05.2006","article-title":"Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide","volume":"26","author":"Brahmachari","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0040","doi-asserted-by":"crossref","unstructured":"Cabezas R, Avila MF, Torrente D, El-Bach\u00e1 RS, Morales L, Gonzalez J, Barreto GE (2013) Astrocytes role in Parkinson: a double-edged sword. In: Neurodegenerative Diseases (Kishore, U., ed), p Ch. 20 Rijeka: InTech.","DOI":"10.5772\/54305"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0045","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","article-title":"6-Hydroxydopamine-induced alterations in blood\u2013brain barrier permeability","volume":"22","author":"Carvey","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","article-title":"The blood\u2013brain barrier in neurodegenerative disease: a rhetorical perspective","volume":"111","author":"Carvey","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2017.04.035","article-title":"Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease","volume":"378","author":"Costa-Mallen","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-3806(01)00218-8","article-title":"Neonatal iron exposure induces oxidative stress in adult Wistar rat","volume":"130","author":"Dal-Pizzol","year":"2001","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0065","doi-asserted-by":"crossref","unstructured":"Dashtipour K, Liu M, Kani C, Dalaie P, Obenaus A, Simmons D, Gatto NM, Zarifi M (2015) Iron accumulation is not homogenous among patients with Parkinson\u2019s disease. Parkinson\u2032s Dis 2015:8.","DOI":"10.1155\/2015\/324843"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","article-title":"Decreased ferritin levels in brain in Parkinson's disease","volume":"55","author":"Dexter","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","article-title":"Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson\u2019s disease after peripheral administration","volume":"118","author":"Dexter","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","article-title":"Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease","volume":"83","author":"Faucheux","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0085","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s11064-007-9290-4","article-title":"Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells","volume":"32","author":"Gaasch","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0090","doi-asserted-by":"crossref","unstructured":"Gerlach M, Double KL, Youdim MBH, Riederer P (2006) Potential sources of increased iron in the substantia nigra of parkinsonian patients. In: Parkinson\u2019s Disease and Related Disorders (Riederer, P. et al., eds), pp 133\u2013142 Vienna: Springer Vienna.","DOI":"10.1007\/978-3-211-45295-0_21"},{"issue":"Suppl 2","key":"10.1016\/j.neuroscience.2017.08.023_b0095","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.parkreldis.2008.04.028","article-title":"Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease","volume":"14","author":"Gerlach","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/1531-8257(200101)16:1<131::AID-MDS1008>3.0.CO;2-O","article-title":"Assessment of plasma lactoferrin in Parkinson's disease","volume":"16","author":"Grau","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0105","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/aww022","article-title":"Iron and dopamine: a toxic couple","volume":"139","author":"Hare","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1039\/B816188G","article-title":"Quantitative elemental bio-imaging of Mn, Fe, Cu and Zn in 6-hydroxydopamine induced Parkinsonism mouse models","volume":"1","author":"Hare","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/10715769900301611","article-title":"Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning","volume":"31","author":"He","year":"1999","journal-title":"Free Radic Res"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02252926","article-title":"Brain iron and ferritin in Parkinson's and Alzheimer's diseases","volume":"2","author":"Jellinger","year":"1990","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0125","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2006.04.003","article-title":"Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age","volume":"28","author":"Kaur","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0300-483X(00)00231-6","article-title":"The Haber-Weiss reaction and mechanisms of toxicity","volume":"149","author":"Kehrer","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0135","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jps.23433","article-title":"Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure","volume":"102","author":"Komazawa","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood\u2013brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00702-010-0434-3","article-title":"Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease","volume":"118","author":"Lv","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0150","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.410360612","article-title":"Complex I, iron, and ferritin in Parkinson's disease substantia nigra","volume":"36","author":"Mann","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0155","first-page":"611","article-title":"Magnetic resonance imaging markers for early diagnosis of Parkinson's disease","volume":"7","author":"Marino","year":"2012","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2741\/e711","article-title":"Brain MRI in Parkinson's disease","volume":"6","author":"Meijer","year":"2014","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0165","doi-asserted-by":"crossref","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders","volume":"2","author":"Mills","year":"2010","journal-title":"Future Med Chem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2009.12.018","article-title":"Selection of reference genes for gene expression studies in rat oligodendrocytes using quantitative real time PCR","volume":"187","author":"Nelissen","year":"2010","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0175","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10534-012-9523-0","article-title":"Iron toxicity in neurodegeneration","volume":"25","author":"Nunez","year":"2012","journal-title":"Biometals"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0180","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuroimage.2012.02.066","article-title":"Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease","volume":"61","author":"Ohlin","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1756285613511507","article-title":"A review of the use of magnetic resonance imaging in Parkinson\u2019s disease","volume":"7","author":"Pyatigorskaya","year":"2014","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0190","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","article-title":"Blood\u2013brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons","volume":"101","author":"Rite","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrn3453","article-title":"Iron metabolism in the CNS: implications for neurodegenerative diseases","volume":"14","author":"Rouault","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0270(93)90147-J","article-title":"A one-step immunohistochemical method for detection of blood\u2013brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry","volume":"46","author":"Schmidt-Kastner","year":"1993","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nurt.2007.05.006","article-title":"Iron in chronic brain disorders: imaging and neurotherapeutic implications","volume":"4","author":"Stankiewicz","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0361-9230(86)90119-X","article-title":"Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry","volume":"17","author":"Stromberg","year":"1986","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0215","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00216-005-3423-x","article-title":"Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats","volume":"383","author":"Tarohda","year":"2005","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0220","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0225","doi-asserted-by":"crossref","first-page":"e112941","DOI":"10.1371\/journal.pone.0112941","article-title":"Magnetic resonance imaging (MRI) to study striatal iron accumulation in a rat model of Parkinson's disease","volume":"9","author":"Virel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0240","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1523\/JNEUROSCI.0944-06.2006","article-title":"Endothelial proliferation and increased blood\u2013brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia","volume":"26","author":"Westin","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(95)11490-N","article-title":"Activated microglia cause superoxide-mediated release of iron from ferritin","volume":"190","author":"Yoshida","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0250","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","article-title":"Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease","volume":"116","author":"Zecca","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2017.08.023_b0260","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2017.01.003","article-title":"Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease","volume":"36","author":"Zhu","year":"2017","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217305894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217305894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:02:05Z","timestamp":1719392525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452217305894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":52,"alternative-id":["S0306452217305894"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2017.08.023","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}